Novapridep M 2mg/500mg/15mg Tablet
Marketer
Organic Laboratories
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Novapridep M 2mg/500mg/15mg Tablet
Glucoprime Trio 2mg/500mg/15mg tablets offer a combined approach to managing blood glucose. This medication, used alongside diet and exercise, enhances glycemic control in adults with type 2 diabetes. It facilitates improved insulin utilization, resulting in reduced blood sugar. Always adhere to your physician's prescribed dosage and regimen for Glucoprime Trio 2mg/500mg/15mg tablets. Ingestion with food is recommended to minimize gastrointestinal discomfort. If a dose is missed, take it promptly; however, if the next dose is imminent, omit the missed dose and resume your usual schedule. Never double the dose. An overdose can cause hypoglycemia (low blood sugar). Concurrent use with other antidiabetic medications, alcohol consumption, or skipped meals may increase hypoglycemia risk. Regular blood glucose monitoring is essential. Common side effects may include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals should seek medical advice before use. Renal function tests will be assessed before treatment initiation. Limit alcohol consumption to mitigate potential side effect exacerbation.
Primary Ingredients of Novapridep M 2mg/500mg/15mg Tablet
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Novapridep M 2mg/500mg/15mg Tablet
Managing type 2 diabetes
Major Benefits of Novapridep M 2mg/500mg/15mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Novapridep M 2mg/500mg/15mg tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with food.
Common Side effects of Novapridep M 2mg/500mg/15mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Novapridep M 2mg/500mg/15mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Novapridep M 2mg/500mg/15mg tablet whole; do not break, crush, or chew it. Administer this medication with a meal.
How Novapridep M 2mg/500mg/15mg Tablet works:
Novapridep M tablets (2mg/500mg/15mg) combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. Their varied mechanisms of action enhance blood sugar management when monotherapy or dual therapy proves inadequate. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose levels. Metformin, a biguanide, decreases hepatic glucose production, slows intestinal glucose absorption, and improves insulin sensitivity. Pioglitazone, a thiazolidinedione, further augments insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Novapridep M 2mg/500mg/15mg tablets with alcohol is not advisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Novapridep M 2mg/500mg/15mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against any risks before prescribing. Seek medical advice before taking this medication.
Breast feedingCONSULT YOUR DOCTOR
The use of Novapridep M 2mg/500mg/15mg tablets while breastfeeding is likely inadvisable. Available evidence from humans indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingCAUTION
Driving may be impaired if your blood glucose levels are abnormally low or elevated. Refrain from driving if such symptoms arise.
KidneyCAUTION
Exercise caution when administering Novapridep M 2mg/500mg/15mg tablets to individuals with kidney impairment; dosage modification may be necessary. Consult a physician for guidance. Avoid using Novapridep M 2mg/500mg/15mg tablets in patients exhibiting severe kidney disease. Close monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Novapridep M 2mg/500mg/15mg tablets cautiously, potentially requiring dose modification. Consult a physician for guidance. Novapridep M 2mg/500mg/15mg tablets are contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Novapridep M 2mg/500mg/15mg Tablet :
Should you forget a Novapridep M 2mg/500mg/15mg Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Novapridep M 2mg/500mg/15mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently